Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
14 Nov 2016 | Asia Pacific | Market Research
Analysis of the Indonesian Clinical Laboratories Market
Increase in Test Volumes Due to Universal Health Coverage will Boost Market Growth Across All Segments
Given the ever-increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from health settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinic laboratory diagnostics. Effective delivery of healthcare services has created a business and technology convergence be...
$1,500.00 -
24 Jan 2017 | Asia Pacific | Market Research
Game-changing Strategies of APAC Pharma Companies
Growing Focus on Specific Therapy Areas and Shift Towards Value-based Delivery Model Expected to Boost Pharma Market
Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...
$1,500.00 -
23 Mar 2017 | Asia Pacific | Market Research
APAC Molecular Diagnostics Market, Forecast to 2021
Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth
The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...
$4,950.00 -
20 Apr 2017 | Asia Pacific | Market Research
The Philippines Transformational Healthcare Insights, 2016
Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage
The Philippines is a part of the Association of Southeast Asian Nations (ASEAN) community and one of the fastest growing healthcare markets in the region. With regard to healthcare, the Philippine Government has been looking at ways to achieve 100% enrolment to PhilHealth by 2020. One of the means is by mandating all Filipinos to enrol to PhilHealt...
$1,500.00 -
19 Jun 2017 | Asia Pacific | Market Research
Growth Opportunities in the APAC IVD Market, Forecast to 2021
Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market
The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016. Research Scope: • Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions: o Immunochemistry o Self-monitoring Blood Glucose (SMBG) Meter o Hematology o Point-of-care...
$4,950.00 -
22 Jun 2017 | Asia Pacific | Market Research
Malaysia, Singapore, and Indonesia Transformational Health Insights, 2017–2022
Rapid Growth, Reforms, and Partnerships are Transforming Healthcare Systems in Malaysia, Singapore, and Indonesia
Southeast Asia (SEA) is emerging as the gold mine for both local and international healthcare vendors. Within SEA, Malaysia, Singapore, and Indonesia still have unexplored and under-served markets providing boundless opportunities for healthcare vendors with innovative products and services. To be able to capitalize on the market, medical device ma...
$1,500.00 -
10 Jan 2018 | Asia Pacific | Market Research
APAC Biosimilar Market, Forecast 2025
Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth
Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Ko...
$4,950.00 -
12 Nov 2018 | Asia Pacific | Market Research
Analysis of the Singapore Clinical Laboratories Market, Forecast to 2021
Laboratory Automation is Driving the Growth of the Clinical Laboratories Market in the Country
Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...
$1,500.00 -
28 Mar 2019 | Asia Pacific | Market Research
Thailand Clinical Laboratories Market, Forecast to 2025
Rising Demand for Diagnostics Services from the Ageing Population and Growing Prevalence of Chronic Diseases to Drive Market Growth
This study focuses on clinical lab services in Thailand. A detailed analysis is provided on clinical testing services at public hospital labs and private hospital labs. Specialised labs are integrated into the independent reference labs segment. Certain trends with regard to physician office labs (POLs) in retail clinics have been mentioned in the ...
$1,500.00 -
28 Mar 2019 | Asia Pacific | Market Research
Malaysian Clinical Laboratories Market, Forecast to 2025
Shift toward Preventive Healthcare is Driving Market Growth
The market for healthcare services in Malaysia is less developed, with many clinical testing services being unavailable outside of cities. Unsubstantiated disease and unconfirmed mortality diagnoses are common in the country despite universal care, significant mixed investment in the local healthcare system, and health expenditure favourable to oth...
$1,500.00
